A previous study reported that CSF1 blockade in ovarian cancer models resulted in a significant reduction in CD163+ M2-like TAMs, with a concomitant increase in M1-polarized macrophages producing CXCL10, a chemokine crucial for T-cell recruitment. This evidence concerns the gene CD163 and ovarian cancer.